Acadia Healthcare (ACHC) director granted 6,331-share equity award, now holds 28,152
Rhea-AI Filing Summary
Fucci Michael reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Michael Fucci received a grant of 6,331 shares of common stock as compensation. The shares were awarded at no cash cost to him and will vest over a three-year period in equal yearly installments beginning on May 6, 2027. After this grant, he directly holds a total of 28,152 shares of Acadia Healthcare common stock. This is a routine equity award rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 6,331 shares
Net Buy
1 txn
Insider
Fucci Michael
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 6,331 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 28,152 shares (Direct)
Footnotes (1)
- F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
Key Figures
Shares granted: 6,331 shares
Grant price: $0.00 per share
Total holdings after grant: 28,152 shares
+2 more
5 metrics
Shares granted
6,331 shares
Equity award on May 6, 2026
Grant price
$0.00 per share
Reported transaction price for award
Total holdings after grant
28,152 shares
Direct ownership following transaction
Vesting period
3 years
Equal yearly installments
Vesting start date
May 6, 2027
First installment vesting date
Key Terms
Grant, award, or other acquisition, vesting, Form 4
3 terms
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
vesting financial
"Shares will vest over a 3-year period in equal yearly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did ACHC director Michael Fucci report on this Form 4?
Director Michael Fucci reported receiving 6,331 shares of Acadia Healthcare common stock as an equity award. The grant was recorded at a price of $0.00 per share, indicating a compensation-related award rather than an open-market purchase, and increased his direct holdings to 28,152 shares.
Is Michael Fucci’s ACHC Form 4 transaction a stock purchase or a grant?
The transaction is a grant, not a stock purchase. Fucci acquired 6,331 shares of Acadia Healthcare common stock as a “Grant, award, or other acquisition,” with a reported price of $0.00 per share, consistent with a compensation-related equity award rather than a cash-funded market trade.
What is the vesting schedule for Michael Fucci’s new ACHC stock award?
The 6,331-share award will vest over three years in equal yearly installments. Vesting begins on May 6, 2027, according to the footnote, meaning the shares become owned outright in stages each year, aligning his compensation with longer-term performance at Acadia Healthcare.
Does the ACHC Form 4 show any stock sales by Michael Fucci?
No stock sales are reported in this Form 4. The filing shows a single acquisition transaction coded as “A” for a grant, award, or other acquisition of 6,331 shares, with no corresponding sale or disposition entries, indicating a net increase in his Acadia Healthcare share holdings.